British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

[PDF][PDF] Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

C Maaser, A Sturm, SR Vavricka… - Journal of Crohn's …, 2019 - academic.oup.com
This new diagnostic consensus guideline is a joint project of the European Crohn's and
Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal …

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

NA Kennedy, GA Heap, HD Green… - The lancet …, 2019 - thelancet.com
Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …

Evaluation of abnormal liver function tests

JK Limdi, GM Hyde - Postgraduate medical journal, 2003 - academic.oup.com
Abstract Interpretation of abnormalities in liver function tests is a common problem faced by
clinicians. This has become more common with the introduction of automated routine …

[HTML][HTML] HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's disease

A Sazonovs, NA Kennedy, L Moutsianas, GA Heap… - Gastroenterology, 2020 - Elsevier
Background & Aims Anti–tumor necrosis factor (anti-TNF) therapies are the most widely
used biologic drugs for treating immune-mediated diseases, but repeated administration can …

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott… - Gut, 2020 - gut.bmj.com
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems
globally. Early insights have been made possible by rapid sharing of data from China and …

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

A Sturm, C Maaser, E Calabrese… - Journal of Crohn's …, 2019 - academic.oup.com
There are several scoring systems presently available to classify disease severity in
ulcerative colitis [UC] within the multiple domains of disease activity, which aid objective …

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

NA Kennedy, JR Goodhand, C Bewshea, R Nice… - Gut, 2021 - gut.bmj.com
Objective Antitumour necrosis factor (anti-TNF) drugs impair protective immunity following
pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious …

Dietary practices and beliefs in patients with inflammatory bowel disease

JK Limdi, D Aggarwal… - Inflammatory bowel …, 2016 - academic.oup.com
Background An epidemiological association implicating diet in IBD risk or protection is
widely accepted. Patients with IBD often make links to diet, but there is a dearth of literature …